Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 994 entries
View as:

Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03023878 Org: User:
Start: 03/13/17 End: 10/28/19 Due: 10/28/20

Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04260191 Org: User:
Start: 06/29/20 End: 06/02/22 Due: 06/02/23

Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT02739984 Org: User:
Start: 05/17/16 End: 08/03/17 Due: 08/03/18

Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01696396 Org: User:
Start: 12/04/12 End: 04/10/18 Due: 04/10/19

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT02010931 Org: User:
Start: 09/30/13 End: 06/30/14 Due: 06/30/15

Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim

Phase: N/A Priority: Normal
NCT ID: NCT01752907 Org: User:
Start: 01/17/13 End: 12/15/14 Due: 12/15/15

A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis

Phase: N/A Priority: Normal
NCT ID: NCT04057937 Org: User:
Start: 10/16/19 End: 06/07/21 Due: 06/07/22

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01988103 Org: User:
Start: 07/09/13 End: 12/15/15 Due: 12/15/16

Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01285310 Org: User:
Start: 12/09/10 End: 09/10/12 Due: 09/10/13

Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00456092 Org: User:
Start: 03/05/07 End: 05/09/09 Due: 05/09/10

Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders

Phase: N/A Priority: Normal
NCT ID: NCT01624142 Org: User:
Start: 06/01/12 End: 05/11/18 Due: 05/11/19

Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT03476239 Org: User:
Start: 10/18/17 End: 04/08/21 Due: 04/08/22

Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00508404 Org: User:
Start: 05/09/07 End: 06/12/12 Due: 06/12/13

Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01755442 Org: User:
Start: 11/30/12 End: 01/31/13 Due: 01/31/14

Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT04857606 Org: User:
Start: 05/24/21 End: 07/19/23 Due: 07/19/24

Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)

Phase: N/A Priority: Normal
NCT ID: NCT01347073 Org: User:
Start: 07/31/11 End: 03/31/13 Due: 03/31/14

Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02756845 Org: User:
Start: 08/16/17 End: 11/29/22 Due: 11/29/23

CAMEO: Canadian Methotrexate and Etanercept Outcome Study

Phase: N/A Priority: Normal
NCT ID: NCT00654368 Org: User:
Start: 06/30/08 End: 02/28/13 Due: 02/28/14

Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00146224 Org: User:
Start: 09/30/05 End: 01/31/07 Due: 01/31/08

Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00511459 Org: User:
Start: 07/31/07 End: 05/31/14 Due: 05/31/15

Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00448786 Org: User:
Start: 02/28/07 End: 03/31/09 Due: 03/31/10

A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab

Phase: N/A Priority: Normal
NCT ID: NCT00508625 Org: User:
Start: 06/30/06 End: 11/30/11 Due: 11/30/12

A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa

Phase: N/A Priority: Normal
NCT ID: NCT00119613 Org: User:
Start: 12/31/02 End: 04/30/07 Due: 04/30/08

A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03776032 Org: User:
Start: 09/14/99 End: 02/27/02 Due: 02/27/03

Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00322400 Org: User:
Start: 03/31/06 End: 01/31/12 Due: 01/31/13